07 August 2010
Antimicrobial activity of ozonated water
Dariusz BialoszewskiABCDEFG, Ewa BocianBCDEF, Bozena BukowskaB, Magdalena CzajkowskaB, Beata Sokol-LeszczynskaB, Stefan TyskiABCDEFGMed Sci Monit 2010; 16(9): MT71-75 :: ID: 881113
Abstract
Background: The purpose of this study was to analyze basic bactericidal and fungicidal activity of ozonated water according to EN 1040 “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics” and EN 1275 “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of basic fungicidal or basic yeasticidal activity of chemical disinfectants and antiseptics” with additional clinical multidrug-resistant bacterial strains and evaluate whether the ozonated water acts as a rapid and efficient antimicrobial agent and as such could be applied during intraoperative ozone treatment for tissue protection against infection with pathogenic bacteria.
Meterial/Methods: A prototype device for intraoperative ozone therapy was used. Besides standard bacterial and fungal strains, 60 clinical bacterial isolates were analyzed.
Results: The ozone concentration in ozonated water was sufficient to kill almost all cells of the bacterial and yeast strains tested after 30 seconds. Effective action against Aspergillus brasiliensis spores required a longer time than those required in the case of bacterial cells or vegetative cells of yeast.
Conclusions: The prototype device used in our study produced high ozone concentrations in freshly prepared ozonated water. This liquid complied with the requirements of the EN Standards: basic bactericidal and basic yeasticidal activities.
Keywords: Microbial Sensitivity Tests, Bacteria - drug effects, Aspergillus - drug effects, Anti-Infective Agents - pharmacology, Ozone - pharmacology, Water - pharmacology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952